Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Antimanic Drug Use in Pregnancy
This clinical trial update reports the completion of a study examining the use of antimanic medications during pregnancy.
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency [Phase 4]
Phase 4 trial evaluating lamotrigine as add-on therapy for bipolar disorder and cocaine dependence; results were posted in 2013.
-
CLINICAL_TRIALS research · 2013-09-26Clinical Trial Update: Involvement of the Sodium Pump and Endogenous Digitalis-like Compounds in Bipolar Disorder
This completed clinical study investigated the involvement of the sodium pump and endogenous digitalis-like compounds in bipolar disorder.
-
FDA approval · 2013-09-19FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone filed by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder [Phase 2]
Phase 2 trial evaluating eslicarbazepine acetate (BIA 2-093) for acute manic episodes in Bipolar I disorder; the study was terminated but re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-09-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ziprasidone hydrochloride from Apotex Corp., confirming a generic version of the antipsychotic. …
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Series Studies of Bipolar Disorder-Valproate add-on Memantine [Phase 2, Phase 3]
A series of Phase 2 and Phase 3 trials evaluated memantine added to valproate for bipolar disorder, with the studies now completed.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Add-on Dextromethorphan in Bipolar Disorders [Phase 3]
A Phase 3 trial evaluating add-on dextromethorphan for bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People [NA]
This completed clinical trial from Dartmouth-Hitchcock Medical Center evaluated health care management and rehabilitation skills training fo…
-
CLINICAL_TRIALS research · 2013-09-02Clinical Trial Update: Female Experiences and Brain Activity
A completed clinical trial update from King's College London investigating female experiences and brain activity in Attention Deficit Hypera…
-
FDA approval · 2013-08-30FDA Approved: RISPERIDONE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for risperidone submitted by Par Health USA, LLC (ANDA 077494).
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression [NA]
A clinical trial evaluated whether adding ketamine to electroconvulsive therapy improves outcomes for major depressive disorder and bipolar …
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder [Phase 2]
A Phase 2 double-blind, placebo-controlled trial of riluzole in pediatric bipolar disorder was terminated with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Thinking Skills for Work in Severe Mental Illness [NA]
Clinical trial update indicating completion of a study on thinking skills for work in severe mental illness, covering multiple psychiatric c…
-
FDA approval · 2013-08-13FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2013-08-13FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Optimizing Electroconvulsive Therapy for Depression [Phase 4]
A Phase 4 clinical trial update on optimizing electroconvulsive therapy for depression, with conditions including major depressive disorder …
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium [Phase 4]
A Phase 4 longitudinal study evaluating the neuroprotective and neurotrophic effects of lithium in bipolar disorder and bipolar depression h…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence [NA]
This pilot trial evaluates citicoline as an add-on therapy for patients with bipolar disorder or major depressive disorder who also have amp…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder [Phase 2]
A Phase 2 trial assessed the efficacy and safety of eslicarbazepine acetate for acute manic episodes in Bipolar I Disorder; the study is com…
-
FDA approval · 2013-07-31FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie Inc. This action represents an approved supplement t…
-
FDA approval · 2013-07-30FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Abilify (aripiprazole) by Otsuka America Pharmaceutical, Inc. The action results in updated labe…
-
FDA approval · 2013-07-29FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) by Novartis Pharmaceuticals Corporation, typically resulting in upda…
-
FDA approval · 2013-07-25FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for ziprasidone under an ANDA, indicating an approved change to the…
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) [Phase 3]
Phase 3 trial assessing safety and efficacy of ziprasidone in children and adolescents with bipolar I disorder (manic or mixed) has complete…